AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 68 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $37,841 | -38.6% | 20,678 | -58.4% | 0.00% | – |
| Q4 2023 | $61,637 | -38.8% | 49,707 | -43.8% | 0.00% | – |
| Q3 2023 | $100,777 | -34.1% | 88,401 | -47.1% | 0.00% | – |
| Q2 2023 | $152,990 | +2.9% | 167,202 | -37.0% | 0.00% | -100.0% |
| Q1 2023 | $148,656 | -30.8% | 265,267 | -28.7% | 0.00% | – |
| Q4 2022 | $214,666 | +63.9% | 372,038 | -9.9% | 0.00% | – |
| Q3 2022 | $131,000 | -20.6% | 412,713 | -11.8% | 0.00% | – |
| Q2 2022 | $165,000 | -42.9% | 467,964 | +16.4% | 0.00% | – |
| Q1 2022 | $289,000 | +95.3% | 402,184 | +515.0% | 0.00% | – |
| Q4 2021 | $148,000 | +146.7% | 65,401 | +213.9% | 0.00% | – |
| Q3 2021 | $60,000 | -9.1% | 20,833 | +20.0% | 0.00% | – |
| Q2 2021 | $66,000 | -63.5% | 17,364 | -67.5% | 0.00% | – |
| Q1 2021 | $181,000 | -31.7% | 53,392 | -43.6% | 0.00% | – |
| Q4 2020 | $265,000 | +204.6% | 94,664 | +173.8% | 0.00% | – |
| Q3 2020 | $87,000 | -86.3% | 34,580 | -58.8% | 0.00% | -100.0% |
| Q1 2020 | $637,000 | +57.3% | 83,972 | +31.1% | 0.01% | +66.7% |
| Q4 2019 | $405,000 | +51.7% | 64,042 | -5.9% | 0.00% | +50.0% |
| Q3 2019 | $267,000 | -21.2% | 68,052 | -2.9% | 0.00% | -33.3% |
| Q2 2019 | $339,000 | +653.3% | 70,077 | +760.7% | 0.00% | – |
| Q4 2018 | $45,000 | -60.9% | 8,142 | -37.6% | 0.00% | -100.0% |
| Q3 2018 | $115,000 | -1.7% | 13,048 | +11.1% | 0.00% | 0.0% |
| Q2 2018 | $117,000 | +4.5% | 11,748 | +105.6% | 0.00% | 0.0% |
| Q3 2017 | $112,000 | -52.5% | 5,713 | -77.7% | 0.00% | -66.7% |
| Q1 2017 | $236,000 | +98.3% | 25,662 | +124.1% | 0.00% | +200.0% |
| Q4 2016 | $119,000 | -56.1% | 11,451 | -61.7% | 0.00% | -66.7% |
| Q3 2016 | $271,000 | +48.1% | 29,891 | +22.0% | 0.00% | +50.0% |
| Q2 2016 | $183,000 | +17.3% | 24,502 | +41.8% | 0.00% | 0.0% |
| Q1 2016 | $156,000 | +67.7% | 17,276 | +138.8% | 0.00% | +100.0% |
| Q4 2015 | $93,000 | -26.2% | 7,236 | -44.6% | 0.00% | -50.0% |
| Q3 2015 | $126,000 | +40.0% | 13,064 | +49.3% | 0.00% | +100.0% |
| Q2 2015 | $90,000 | -36.6% | 8,753 | -31.5% | 0.00% | -50.0% |
| Q1 2015 | $142,000 | +7.6% | 12,775 | +12.3% | 0.00% | 0.0% |
| Q4 2014 | $132,000 | +2540.0% | 11,378 | +4721.2% | 0.00% | – |
| Q3 2014 | $5,000 | – | 236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,887,535 | $37,128,000 | 4.83% |
| FT Options LLC | 190,400 | $1,451,000 | 2.19% |
| DAFNA Capital Management LLC | 135,738 | $2,670,000 | 1.66% |
| Nantahala Capital Management | 1,367,947 | $26,908,000 | 1.32% |
| Perceptive Advisors | 3,260,000 | $64,124,000 | 1.22% |
| EAM Investors, LLC | 235,470 | $4,632,000 | 0.62% |
| 361 CAPITAL LLC | 139,489 | $2,744,000 | 0.53% |
| Opus Point Partners Management, LLC | 21,009 | $413,000 | 0.37% |
| EAGLE ASSET MANAGEMENT INC | 3,043,867 | $59,629,000 | 0.34% |
| Piermont Capital Management Inc. | 27,770 | $546,000 | 0.18% |